tiprankstipranks
Trending News
More News >

Lipella Pharmaceuticals re-signs manufacturing collab with Cook MyoSite

Lipella Pharmaceuticals (LIPO) announced that it has re-signed its manufacturing collaboration agreement with Cook MyoSite to support Chemistry, Manufacturing and Control, CMC, documentation supporting our clinical products LP-10 and LP-310. Dr. Jonathan Kaufman, Chief Executive Officer and Co-Founder of Lipella, said, “We are pleased to renew our collaboration with Cook MyoSite, a trusted partner with a strong track record in high-quality manufacturing. This CMC collaboration is increasingly valuable to Lipella as our clinical pipeline matures toward commercializable assets.”

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1